SEARCH

SEARCH BY CITATION

References

  • 1
    Loo FD, Palmer DW, Soergel KH, Kalbfleisch JH, Wood CM. Gastric emptying in patients with diabetes mellitus. Gastroenterology 1984; 86: 48594.
  • 2
    Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 67580.
  • 3
    Wisen O, Hellström PM. Gastrointestinal motility in obesity. J Int Med 1989; 84: 86872.
  • 4
    Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22: 5037.
  • 5
    Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labelled octanoic acid breath test. Gastroenterology 1993; 104: 16407.
  • 6
    Lee JS, Camilleri M, Zinsmeister AR, et al. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol 2000; 95: 275161.
    Direct Link:
  • 7
    Maes BD, Hiele MI, Geypens BJ, Rutgeerts PJ, Ghoos YF, Vantrappen G. Pharmacological modulation of gastric emptying rate of solids as measured by the carbon labelled octanoic acid breath test: influence of erythromycin and propantheline. Gut 1994; 35: 3337.
  • 8
    Horowitz M, Harding PE, Maddox AF. Gastric and esophageal emptying in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1989; 32: 1519.
  • 9
    Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height–weight formula validated in infants, children, and adults. J Pediatr 1978; 93: 626.
  • 10
    Borovicka J, Lehmann R, Kunz P, et al.Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. Am J Gastroenterol 1999; 94: 286673.
    Direct Link:
  • 11
    Duan LP, Braden B, Caspary WF, Lembcke B. Influence of cisapride on gastric emptying of solids and liquids monitored by 13C breath tests. Dig Dis Sci 1995; 40: 22006.
  • 12
    Dutta U, Padhy AK, Ahuja V, Sharma MP. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. Trop Gastroenterol 1999; 20: 1169.
  • 13
    Ishii K, Tanabe S, Mitsuhashi T, Saigenji K. Influence on glycemic control of improved diabetic gastroparesis by long-term cisapride therapy. Jpn J Gastroenterol 1995; 92: 172433.
  • 14
    Stacher G, Schernthaner G, Francesconi M, et al.Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 1999; 84: 235762.
  • 15
    Johansson UB, Wredling RA, Adamson UC, Lins PE. A randomised study evaluating the effects of cisapride on variability and quality of life parameters in insulin-dependent diabetes mellitus patients. Diabetes Metab 1999; 25: 3149.
  • 16
    Braden B, Adams S, Duan L-P, et al.13C-acetate breath test accurately reflects gastric emptying of liquids in liquid and semisolid test meals. Gastroenterology 1995; 108: 124550.
  • 17
    Ziegler D, Schadewaldt P, Pour Mirza A, et al.[13C]Octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 1996; 39: 82330.DOI: 10.1007/s001250050516
  • 18
    Schadewaldt P, Schommartz B, Wienrich G, Brösicke H, Piolot R, Ziegler D. Application of isotope-selective nondispersive infrared spectrometry (IRIS) for evaluation of [13C]octanoic acid gastric-emptying breath tests: comparison with isotope ratio mass spectrometry (IRMS). Clin Chem 1997; 43: 51822.
  • 19
    Braden B, Schäfer F, Caspary WF, Lembcke B. Nondispersive isotope-selective infrared spectroscopy: a new analytical method for 13C-urea breath tests. Scand J Gastroenterol 1996; 31: 4425.
  • 20
    Koletzko S, Haisch M, Seeboth I, et al. Isotope selective nondispersive infrared spectrometry for detection of Helicobacter pylori infection with 13C-urea breath test. Lancet 1995; 345: 9612.
  • 21
    Silvers D, Kipnes M, Broadstone V, et al.Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 1999; 20: 43853.
  • 22
    Farup CE, Leidy NK, Murray M, Williams GR, Helbers L, Quigley EM. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 1998; 21: 1699706.